Placebogenic Potential is no Reason to Favour Pharmaceutical Advertising
Advertisements for pharmaceuticals may promote placebo responses by generating an expectation of therapeutic success. Some cite this as reason to favour Direct to Consumer Advertising of Prescription Pharmaceuticals (DTCA). Against this, I show placebo responses to emanate from beliefs rendered unjustified by the influence of a conditioning process. I argue that drug safety and efficacy are material properties and that unjustified beliefs in these domains entail costs to autonomy that outweigh any prudential gains attending a placebo response. I conclude that its placebogenic potential ought not to count as reason to favour DTCA.
KeywordsPharmaceutical Advertising Placebo Ethics Autonomy
- Amanzio, M., & Benedetti, F. (1999). Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. Journal of Neuroscience, 19(1), 484–494.Google Scholar
- Amgen Wyeth. (2004). Enbrel TV Ad. Cited July 11, 2013. http://www.youtube.com/watch?v=7JLN_QR6Wl8.
- Bizer, G. Y., Barden, J. C., & Petty, R. E. (2003). Attitudes. In L. Nadel (Ed.), Encyclopedia of cognitive science. Hampshire: MacMillan.Google Scholar
- Buss, S. (2008). Personal autonomy. The Metaphysics Research Lab, Stanford University. Cited July 11, 2013. http://plato.stanford.edu/entries/personal-autonomy/.
- De Houwer, J. (2009). Conditioning as a source of liking: There is nothing simple about it. In M. Wanke (Ed.), Social psychology of consumer behavior. New York: Taylor and Francis.Google Scholar
- De Houwer, J. (2011). Evaluative conditioning: A review of functional knowledge and mental process theories. In T. R. Schachtman & S. S. Reilly (Eds.), Associative learning and conditioning theory: Human and non-human applications. Oxford: Oxford University Press.Google Scholar
- Eagly, A. H., & Chaiken, S. (1993). The psychology of attitudes. Fort Worth, TX: Harcourt Brace Jovanovich College Publishers.Google Scholar
- Faden, R. R., Beauchamp, T. L., & King, N. M. P. (1986). A history and theory of informed consent. New York: Oxford University Press.Google Scholar
- Foley, R. (2008). An epistemology that matters. In P. J. Weithman (Ed.), Liberal faith: Essays in honor of Philip Quinn. Notre Dame, IN: University of Notre Dame Press.Google Scholar
- Food and Drug Administration. (2001). Guidance for industry: E 10 Choice of control group and related issues in clinical trials. Rockville.Google Scholar
- Giang, D. W., Goodman, A. D., Schiffer, R. B., Mattson, D. H., Petrie, M., Cohen, N., et al. (1996). Conditioning of cyclophosphamide-induced leukopenia in humans. The Journal of Neuropsychiatry and Clinical Neurosciences, 8(2), 194–201.Google Scholar
- Jordan, J. (1996). Pragmatic arguments and belief. American Philosophical Quarterly, 33(4), 409–420.Google Scholar
- Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention and Treatment, 1(1), 1–16.Google Scholar
- Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. Gainesville, FL: University of Florida.Google Scholar
- Pavlov, I. (1927). Conditioned reflexes: An investigation of the physiological activity of the cerebral cortex (G. V. Anrep, Trans.). London: Oxford University Press.Google Scholar
- Pfizer. Lipitor commercial. Cited July 11, 2013. http://www.youtube.com/watch?v=lNFuEcy5ekg.
- Rogers v Whitaker. (1992). 67 Australian Law Journal Reports 47.Google Scholar
- Roullet, B., & Droulers, O. (2005). Pharmaceutical packaging colour and drug expectancy. Advances in Consumer Research, 32, 164–171.Google Scholar
- Silberman, S. (2009). Placebos are getting more effective. Drugmakers are desperate to know why. Cited July 11, 2013. http://www.wired.com/medtech/drugs/magazine/17-09/ff_placebo_effect?currentPage=all.